HHS Recruits New Vaccine Advisers Under Trump Administration
The Department of Health and Human Services has initiated recruitment for new vaccine advisers , according to reporting published by The Hill . The personnel drive marks an operational shift within federal health infrastructure under the Trump administration as officials reconstitute advisory panels that evaluate pharmaceutical data and immunisation guidance. They published 800 words without
mentioning this reality: establishment outlets frame advisory overhauls as neutral administrative adjustments while obscuring institutional capture. Corporate reporting scrutinises the political optics of advisory vacancies, yet systematically ignores how commercial pharmaceutical interests dictate regulatory priorities across administrations. Washington consistently grants private drugmakers
extensive liability exemptions while restricting genuine public scrutiny. This dual standard protects corporate profit margins while deflecting structural scrutiny onto routine personnel rotations. Regulatory bodies continue to operate a revolving door that transfers industry insiders directly into federal evaluation seats. The pattern repeats because we let it. Share this before it disappears
from your feed. The algorithm suppresses what matters. Beat it -- follow @The_Piaz , subscribe on Substack , and share this before it gets buried. Support our work so we can keep exposing what they'd rather you didn't see.